All News

Complications following IUD removal were the focus of this lawsuit.

These are the eight steps for successfully launching virtual visits in low- and high-risk obstetrics and gynecology.

Dr. Charles J. Lockwood sits down with Linda Marie Wetzel, Executive Editor for Contemporary OB/GYN, to discuss the results of the ARRIVE study and what these findings mean for ob/gyns and their patients.

More than half of rural counties in the United States have no hospital obstetrical services, many remaining services are closing at a frightening pace, and maternal and perinatal mortality and/or morbidity are rising as a consequence.

Release of results from the ARRIVE trial has provided answers to some concerns about 39-week induction while leading to some questions about the participants and the implication of the findings for clinical practice. PLUS: CDC updates on Zika virus. Also: FDA warns about tests for rupture of membranes

Dilator therapy can be extremely successful in treating superficial dyspareunia, but compliance is often poor. A new type of vaginal dilator that gives women more control aims to address the issue.

A recent study quantified how much the treatment effect of pharmacologic modalities for female sexual dysfunction could be attributed to the placebo effect.

To fight the opioid epidemic, ob/gyns, like all physicians, are looking for ways to help prevent substance use disorders and enhanced recovery programs (ERAS) could play a role. PLUS: Are EDs screening adolescents with PID for HIV, syphilis? ALSO: Results of a new retrospective study show that a woman’s race may impact how likely she is to have a myomectomy-and alarmingly, whether the procedure is likely to result in morbidity.

A recent study examined whether severe and/or chronic abuse of multiple types during childhood and adolescence increases a woman's risk of endometriosis.

Incidence of acute myocardial infarction (AMI) continues to increase in women during pregnancy and the puerperium. Data from a new study point to underlying factors contributing to that trend. PLUS: Results of a large population-based study of POP procedures provide new insights into what factors other than the material may play a role in the adverse surgical outcomes.

The manufacturer of a device for permanent birth control that reportedly causes serious adverse events has decided to cease selling it at the end of the year. PLUS: Does smoking cessation really = weight gain? Also: Is prenatal depression more common today? 

Ob/gyns and other women’s health providers can help save Title X for their patients and their voices need to be heard on Capitol Hill. That was the clear message from speakers at a recent media event in Washington, DC.

Risk of postop urinary retention may vary depending on when devices are removed.

Uropathogens may not be the only bacteria shared between the vagina and bladder.

Research point to risk as well as benefits of extended adjuvant tamoxifen for ER-positive BCa. PLUS: Should breast cancer screening be risk-based? ALSO: Side effects of cross-sex hormones in transwomen.

A meta-analysis of 140 studies by investigators from the Cochrane Collaboration shows that oxytocin may not be the best choice for prevention of postpartum hemorrhage, despite the current recommendation from the World Health Organization (WHO). PLUS: Commentary on the findings from our Maternal Mortality Series Editor, Carolyn Zelop, MD.

Despite the prevalence of GSM, the condition continues to be under-recognized and undertreated due to a combination of patient and provider factors. Providers need to take the initiative in screening and patient education.

This article reviews recommendations for breastfeeding and current breastfeeding rates; positive maternal health outcomes associated with breastfeeding; and evidence-based practices that enable women to successfully achieve their breastfeeding goals.

Oxytocin is one of the most frequently used drugs during labor but it can also become a major issue in a malpractice case filed after a labor and delivery if there is an adverse outcome. PLUS: Carolyn Zelop, MD, provides commentary on a lawsuit involving a patient death during pregnancy due to cardiomyopathy.

An oral selective estrogen receptor modulator approved for treatment of mild to moderate dyspareunia in menopausal women reduced signs and symptoms of atrophy in the vulva, vestibule, urethral meatus and vagina region, according to results of a prospective open-label pilot study

In women with endometriosis, deep dyspareunia is associated with lower sexual quality of life (QoL), according to a study.

An ob/gyn shares her experience with implementing enhanced recovery after surgery (ERAS) and its effect on patient care at her institution

Mammography is sufficient to predict breast cancer risk in women aged ≥ 60, but in younger women, combining mammography and genetic testing improves the assessment, according to a retrospective case-control study

Recent cryopreservation tank failures have focused a spotlight on procedures used by IVF facilities to safeguard patients’ reproductive tissue. The information here may help ob/gyns and their patients better understand the processes, management, and maintenance of IVF systems.

A study by investigators from New England suggests that a mother’s diet during pregnancy and lactation may have an impact on the microbiome in her infant’s gut. PLUS: Are prenatal vitamin D levels tied to adverse pregnancy outcomes? ALSO: Results of a survey-based study of attending surgeons shows that they play a major role in whether women with breast cancer receive genetic testing.

Ob/gyns must be ready to move quickly when a patient exhibits the sudden and unexpected signs of anaphylactoid syndrome (ASP).